KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Encompass Health (EHC) Operating Income (2016 - 2025)

Historic Operating Income for Encompass Health (EHC) over the last 17 years, with Q3 2025 value amounting to $12.5 million.

  • Encompass Health's Operating Income rose 8656.72% to $12.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $133.2 million, marking a year-over-year increase of 22408.76%. This contributed to the annual value of $61.9 million for FY2024, which is 38740.16% up from last year.
  • Latest data reveals that Encompass Health reported Operating Income of $12.5 million as of Q3 2025, which was up 8656.72% from $45.3 million recorded in Q2 2025.
  • Over the past 5 years, Encompass Health's Operating Income peaked at $49.5 million during Q1 2025, and registered a low of -$239.7 million during Q2 2021.
  • Moreover, its 5-year median value for Operating Income was $5.1 million (2023), whereas its average is -$16.3 million.
  • As far as peak fluctuations go, Encompass Health's Operating Income crashed by 119271.84% in 2021, and later soared by 127500.0% in 2025.
  • Encompass Health's Operating Income (Quarter) stood at -$2.6 million in 2021, then surged by 469.23% to $9.6 million in 2022, then plummeted by 46.88% to $5.1 million in 2023, then soared by 407.84% to $25.9 million in 2024, then plummeted by 51.74% to $12.5 million in 2025.
  • Its last three reported values are $12.5 million in Q3 2025, $45.3 million for Q2 2025, and $49.5 million during Q1 2025.